AFLAC Incorporated · NYSE:AFL
AFLAC — Investor Day (September 2006)
62 slides from AFLAC's investor day presentation, Sep 11, 2006
Slide 1: 2006 Tokyo Analyst Meeting Presentation Slides
2006 Tokyo Analyst Meeting Presentation Slides September 11, 2006 For more information contact: Ken Janke, Jr. or Robin Mullins 800-235-2667, Option 3 Fax: (706) 324-6330 aflac.com Aflac Worldwide Headquarters 1932 Wynnton Road Columbus, GA 31999
Slide 2: Forward-looking statements safe harbor
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors t
Slide 3: Introduction to Aflac Japan
Introduction to Aflac Japan Aki Kan President & Chief Operating Officer, Aflac Japan Life Insurance Policies in Force (FSA Basis, in Millions) 120 112.7 110.8 110.2 109.3 109.6 109.9 100 80 60 40 20 0 3/01 3/02 3/03 3/04 3/05 3/06 Life Industry Aflac Source: Life Insurance Association of Japan, Insu
Slide 4: The Number One Life Insurer in Japan
The Number One Life Insurer in Japan (Policies in Force, FSA Basis, in Millions) 20 Aflac = No. 1 17.8 18 16 14 12 10 8 6 4 2 0 3/75 3/80 3/85 3/90 3/95 3/00 3/06 Third Sector’s Increasing Share (New Policy Sales) 50% 47.7% 45 40 35 30 25 20 15 10 5 0 3/96 3/97 3/98 3/99 3/00 3/01 3/02 3/03 3/04 3/0
Slide 5: National Medical Expenses and Aflac's Market Share
National Medical Expenses (Yen in Trillions) Medical Expenses For elderly National Medical Expenses to National Income ¥ 100 13.2% 14% 90 12 80 9.9% 70 8.9% ¥69 10 60 8 50 ¥41 6 40 ¥32 30 4 20 2 10 0 0 2004 2010 2025 Source: Ministry of Health, Labor and Welfare Aflac’s Share of In-Force Business (F
Slide 6: Aflac's Share of Stand-alone Medical and Competitors
Aflac’s Share of In-Force Business (FSA Basis) Stand-alone Medical (Policies in Thousands) Market Growth Market Share 18,000 100 % 16,000 14,000 80 12,000 10,000 60 8,000 6,000 40 4,000 20 2,000 0 0 3/02 3/03 3/04 3/05 3/06 3/02 3/03 3/04 3/05 3/06 Aflac Alico AXA Fukoku Others Source: Insurance Res
Slide 7: Aflac Japan's Strategy for Growth
Number of Medical Products 160 135 139 140 125 119 120 102 107 88 92 100 87 77 80 69 56 60 49 40 31 20 0 12/00 12/01 12/02 12/03 12/04 12/05 7/06 Stand-alone medical Stand-alone medical and rider *Reflects results of company mergers and companies that have discontinued sales Source: Websites of each
Slide 8: Aflac Japan's Competitive Strengths: Products
Aflac Japan’s Competitive Strengths Products Efficient Distribution Operations Financial Internal Control Strength Aflac Japan’s Competitive Strengths Products Efficient Distribution Operations Financial Internal Control Strength Aflac Japan’s Product Line Third Sector Products First Sector Products
Slide 9: Aflac Japan's Distribution Channels
Aflac Japan’s Competitive Strengths Products Efficient Distribution Operations Financial Internal Control Strength Aflac Japan’s Distribution Channels 1. Affiliated Corporate 2. Independent Corporate 3. Individual 4. Dai-ichi Mutual Life Aflac Japan’s Competitive Strengths Products Efficient Distrib
Slide 10: Aflac Japan's Competitive Strengths
Aflac Japan’s Competitive Strengths Products Efficient Distribution Operations Financial Internal Control Strength Aflac Japan’s Competitive Strengths Products Efficient Distribution Operations Financial Internal Control Strength 8
Slide 11: Japan's Regulatory Environment
Japan’s Regulatory Environment Charles Lake Vice Chairman, Aflac Japan Progress in Financial Regulatory Reform MOF Era FSA Era • Maximum control • Areas of deregulation • Industry protection measures • Administrative • Areas of expanded guidance regulator involvement • Convoy system • Self-responsib
Slide 12: The Program for Further Financial Reform
The Program for Further Financial Reform • Market conduct » Confirmation of customer needs » Allow comparative advertising The Program for Further Financial Reform • Market conduct » Confirmation of customer needs » Allow comparative advertising • Price flexibility The Program for Further Financial
Slide 13: The Program for Further Financial Reform
The Program for Further Financial Reform • Market conduct » Confirmation of customer needs » Allow comparative advertising • Price flexibility • Third-sector reserving rules • New regulations for previously unregulated small-amount, short-term insurance providers The Program for Further Financial Re
Slide 14: Postal Privatization and Social Security Benefits
Postal Privatization Oct. 2007- Government Holding Company (100% of shares held by the government) Postal Postal Postal Postal Delivery Office Savings Insurance Company Company Company Company Oct. 2017- Government Holding Company (at least 1/3 held by the govt.) Postal Postal Postal Postal Delivery
Slide 15: Copayments for Seniors and Health Care Reform
Major Changes in Copayments for Seniors (Age 70 or Over) Apr. 2008 Age Oct. 2006 70-74: Oct. 2002 20% Jan. 2001 Age Intro- 10% Sep. 1997 10% 75-: Jan. 1992 duction 10% Feb. 1983 Fixed Fixed of fixed Introduction of small amount amount rate 20%* 30%** 30%** fixed-amount hike hike 10% *Husband and wif
Slide 16: Aflac Japan Administration
Aflac Japan Administration Hiroshi Yamauchi First Senior Vice President; Chief Administrative Officer, Aflac Japan Maintenance Expenses Per Policy in Force (FSA Basis, 3/06) General Operating Policies Rank by Expenses in Force Cost Assets (In Millions)* (In Thousands) Per Policy 1 Nippon ¥240,737 13
Slide 17: Policies Per Administrative Employee
Number of Policies Per Administrative Employee (FSA Basis, 3/06) Policies Rank by Administrative in Force Policies per Assets Employees (In Thousands) Employee 1 Nippon 10,754 13,411 1,247 2 Dai-ichi 9,253 11,498 1,242 3 Meiji Yasuda 8,755 9,666 1,104 4 Sumitomo 8,149 9,128 1,120 6 Taiyo 2,704 3,368
Slide 18: Benefits of Centralization and Aflac Contact Center
Benefits of Centralization • Generation of time for core jobs at sales offices • Use of time generated Sales agency training e-App promotion, etc. Aflac Contact Center Aflac Contact Center Aflac Call Center (Inquiries from existing policyholders) Aflac Direct Desk (Inquiries from prospective consume
Slide 19: Surrender and Lapse Rates, Persistency
Surrender and Lapse Rates (Individual Insurance Only, FSA Policy Basis) 10 % 9.1 9 8.3 8.2 7.9 8.1 8 7.5 8.1 6.9 6.6 7 6 Life insurance industry 5.0 4.9 5 4.4 4.4 4 4.4 4.1 3 3.5 3.7 3.8 Aflac 2 1 0 1997 1998 1999 2000 2001 2002 2003 2004 2005 Source: Japan Institute of Life Insurance Ratio of Not-T
Slide 20: Aflac Japan Investments
Claims Payments (Yen in Billions) Cancer Medical/Rider MAX No. of days required to pay claims (No. of days) ¥350 Less than 2 days 4 on average 300 3.5 3 250 2.5 200 2 150 1.5 100 1 50 0.5 0 0 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 Source: Internal data Aflac Japan Investments Shigeharu Na
Slide 21: Aflac Investment Organization and Considerations
Aflac Investment Organization Aflac Japan Investment Considerations • Product needs » Long liability durations » Yen-denominated policy liabilities • Credit risk • Aflac Incorporated objectives 2006 Longer-Dated Yen Purchases (Six Months, June 30) Acquisition Cost % of 2006 Remaining (In Billions) N
Slide 22: Average Maturity and Duration; Investment Policy
Average Maturity and Duration (Yen-Denominated, in Years) 19 18.1 18 17.3 17 16 15.3 15.7 15.2 14.9 14.7 15 14 Maturity 12.5 13 12.1 12.3 12 11.6 11.1 11.1 11 10.5 10 9 Duration 8 7 2001 2002 2003 2004 2005 6/05 6/06 Aflac’s Investment Policy All securities must be rated investment grade at the time
Slide 23: Aflac Japan Credit Ratings and Impairment Policy
Aflac Japan Credit Ratings* 2004 2005 6/06 AAA 2.9% 2.9% 3.4% AA 36.0 37.0 38.8 A 33.6 37.0 35.8 BBB 25.8 21.0 20.0 BB or below 1.7 2.1 2.0 Total 100.0% 100.0% 100.0% *At amortized cost Below-Investment-Grade Holdings (June 30, 2006, Yen in Millions) Amortized Unrealized Cost Fair Value Gain (Loss)
Slide 24: Largest Investment Concentrations
Largest Investment Concentrations (June 30, 2006, at Amortized Cost, Yen in Millions) Rating Category Japanese Government Bonds ¥922,329 AA State of Israel* 99,498 A/BBB Credit Suisse Group 89,183 A HSBC 86,162 AA/A Banque Centrale De Tunisie 80,504 BBB HBOS 72,848 AA/A Takefuji 72,053 BBB Republic
Slide 25: Comparison of Yields in Japan
Comparison of Yields in Japan (FSA Basis, March 31) 8% 6.95 7 Aflac Japan 6 5.87 5.22 5 4.65 4.60 4.75 5.20 4.50 3.96 4 4.45 3.66 3.36 2.93 All life insurers 3 in Japan (average) 2.48 2.42 2.29 2.15 1.94 2 2.40 2.13 1.25 1.15 1 3/96 3/97 3/98 3/99 3/00 3/01 3/02 3/03 3/04 3/05 3/06 Interest Rate Mar
Slide 26: Aflac Japan Financial Results
Aflac Japan Financial Results Yuji Arai Senior Vice President; Principal Financial Officer, Aflac Japan Comparison of Premium Income Growth (FSA Basis, 3/01 = 100) 150% 125 100 75 50 3/01 3/02 3/03 3/04 3/05 3/06 Aflac Industry Source: Japan Institute of Life Insurance 24
Slide 27: Premium Income and Total Assets Rankings
Premium Income (FSA Basis, 3/06) Amount Rank Company (In Billions) % Increase 1 Nippon ¥4,841 .3 % 2 Dai-ichi 3,399 (3.7) 3 Sumitomo 3,014 16.8 4 Meiji Yasuda 2,671 (12.2) 5 Alico 1,372 (18.4) 6 Hartford 1,188 10.3 7 Aflac 1,024 7.0 8 Mitsui 964 7.3 9 Daido 870 (1.5) 10 ING 850 39.7 Source: Disclosu
Slide 28: Individual Policies in Force and Investment Margin
Individual Policies in Force (FSA Basis, 3/06, Policies in Thousands) Rank Company No. of Policies % Increase 1 Aflac 17,801 3.9% 2 Nippon 13,411 (3.2) 3 Dai-ichi 11,498 (.8) 4 Meiji Yasuda 9,666 (4.5) 5 Sumitomo 9,128 (2.2) 6 Asahi 7,720 3.4 7 Alico 5,273 9.4 8 Sony 3,815 7.9 9 Gibraltar 3,662 (3.7
Slide 29: Assumed Interest Rates for Product Pricing
Assumed Interest Rates for Product Pricing Jul. Sept. Oct. Jul. Apr. 1994 1995 1996 1999 2001 Cancer life 4.5% 4.5% 3.1% 2.35% 2.35% Care 5.5 4.5 3.1 2.35 2.35 LBL 4.5 3.1 2.35 2.35 Medical 5.5 4.5 3.1 2.35 2.35 Ordinary life 2.35* 1.85 Annuity** 2.15 1.65 *Changed in April 1999 **Periodic payment o
Slide 30: Benefit Ratios and Persistency Rates
Benefit Ratios by Product Traditional cancer life - full CSV 68% - 73% Cancer life - reduced CSV 63% - 68% 21st Century Cancer life - full CSV 60% - 65% 21st Century Cancer life - reduced CSV 55% - 60% Riders to cancer and medical 50% - 60% Ordinary life products 65% - 75% EVER 52% - 57% Persistency
Slide 31: Solvency Margin and Financial Strength Ratings
Solvency Margin, Real Net Asset, Basic Earnings (FSA Basis, 3/06) Solvency Margin 1,100.7% Real Net Asset ¥638 Billion Real Net Asset Ratio* 12.9% Basic Earnings ¥108 Billion Basic Earnings Ratio** 2.2% * Real Net Asset/Total Assets ** Basic Earnings/Total Assets Financial Strength Ratings Rank by P
Slide 32: Aflac Japan Marketing; Pretax Operating Earnings Growth
Pretax Operating Earnings Growth (Yen in Billions) Pretax Total Profit Operating Revenues Margin Earnings 2001 ¥ 905.7 × 11.0% = ¥100.0 2002 956.7 × 11.9 = 114.2 2003 1,014.8 × 12.8 = 130.2 2004 1,075.6 × 13.9 = 149.3 2005 1,146.1 × 14.5 = 166.4 Reflects SFAS 123R beginning in 2002 Aflac Japan Marke
Slide 33: Comparative Cancer and Medical Policy Sales
Comparative Cancer Policy Sales (Stand-alone Basis) 250,000 Aflac Co. A Co. B Co. C Co. D Co. E 200,000 150,000 100,000 50,000 0 1QT 2QT 3QT 4QT 1QT 2QT 3QT 4QT 1QT 2QT 3QT 4QT 1QT 2QT 3QT 4QT 1QT 2QT 2002 2003 2004 2005 2006 Source: Internal data Premium Comparison of Cancer Life Policies (Whole-li
Slide 34: Consumer Confusion and Effect of Administrative Sanctions
Confusion of Consumers with Various Types of Medical Products What do you think of so many insurance companies selling whole-life medical insurance? Can choose the best product - 17% Difficult to choose the best product - 39% Can choose the best product for me in the future if the number of products
Slide 35: Most Preferred Insurer and Premium Comparison
The Most Preferred Insurer for Cancer Life and Medical Insurance Cancer Life Medical Aflac 38 Aflac 20 Alico 12 Alico 12 9 10 Nippon Nippon 7 11 Kampo Kampo 0 10 20 30 40 % 0 10 20 30% Source: Interscope Inc. 8/06 Premium Comparison of Medical Products (Whole-life, Stand-alone Basis) Max. Days Requi
Slide 36: Rider MAX Premiums and Agency Alliances
Average Premiums for Rider MAX Products ¥ 60,000 Rider MAX 55,000 Rider MAX with Care ¥52,663 50,000 45,000 40,000 ¥41,019 35,000 30,000 2003 2004 2005 6-7/06 Excludes conversions Alliance Between Different Types of Agencies Distribution of application forms Affiliated corporate agencies Employees M
Slide 37: Approach to Existing Policyholders and Referrals
Strengthening our Approach to Existing Policyholders Mailing Introduce ・ Hot Mail products that meet Existing ・ Direct mail to existing customer needs policyholders policyholders ・ Policy maintenance Follow-up telephone calls(Hot Call) Call (Contact Center) ・ Outbound ・ Inbound ・ Handle policyholder
Slide 38: Ten Million Aflac Ducks
Ten Million Aflac Ducks Cumulative Number of Toy Ducks (In Millions) 10.0 10 8 6 4 2 0 3 6 9 12 3 6 9 12 3 6 9 12 3 6 7 2003 2004 2005 2006 Rider MAX with Care TV Commercial 36
Slide 39: Aflac Japan Sales
Aflac Japan Sales Hisayuki Shinkai First Senior Vice President; Director of Sales, Aflac Japan New Annualized Premium Sales (Yen in Billions) ¥ 140 ¥128.8 ¥121.2 ¥122.5 120 ¥108.3 100 ¥91.9 80 ¥62.4 ¥60.6 60 40 20 0 2001 2002 2003 2004 2005 6/05 6/06 % Inc. (7.9) 17.9 11.9 1.1 5.1 3.1 (2.8) New Asso
Slide 40: Service Shops and Hojinkai Market Sales
Number of Service Shops 550 505 500 450 400 350 300 250 200 150 100 1QT 2QT 3QT 4QT 1QT 2QT 3QT 4QT 1QT 2QT 3QT 4QT 1QT 2QT 2003 2004 2005 2006 New Annualized Premium Sales in the Hojinkai Market (Yen in Billions) ¥4.9 ¥5 ¥4.1 4 ¥3.6 3 ¥1.8 2 ¥1.3 1 0 2003 2004 2005 6/05 6/06 Aflac Contact Center Fu
Slide 41: Bank Channel Distribution
Bank Channel Distribution Total Banks Number Affiliated Selling of Corporate Aflac Banks Agencies Products Mega, long-term credit and trust banks 11 9 Regional banks 64 61 9 Second-tier regional banks 47 43 14 Credit banks 292 153 66 Total 414 266 89 Percentage Change in New Sales by Dai-ichi Life 4
Slide 42: Sales from a Territory Director's Perspective: Tokyo
Aflac Japan Sales - From a Territory Director’s Perspective Shigehiko Akimoto Senior Vice President; Director of Tokyo Territory, Aflac Japan Aflac’s Penetration Among Companies Listed on the Tokyo Stock Exchange Aflac Customers 91% 1
Slide 43: Strategy for the Existing Tokyo Worksite Market
Strategy for the Existing Tokyo Worksite Market Annualized Premium Sales from MS (First Six Months 2006) Sales offices responsible for agencies affiliated with Tokyo Territory financial institutions 13% 26% Strategy for the Existing Tokyo Worksite Market New annualized premium sales of Hitachi Insur
Slide 44: Penetration of Emerging Market Companies and Banks
Aflac’s Penetration Among Companies Listed on the Emerging Equity Markets* Aflac Customers: 373 companies 54% 46% Non Aflac Customers: 440 companies *JASDAQ, Mothers and Hercules Banks Selling Insurance in the Tokyo Area Number Number of Banks of Branches Regional Banks 4 261 Credit Banks 23 1,006 T
Slide 45: Sales from a Territory Director's Perspective: Shutoken
Aflac Japan Sales - From a Territory Director’s Perspective Hidekatsu Yajima First Vice President; Director of Shutoken Territory, Aflac Japan The Shutoken Territory Shutoken: Tokyo and 6 prefectures 4
Slide 46: The Market in Shutoken Territory
The Market in Shutoken Territory (In Thousands) Number of Area Households Population Country 50,382 126,869 Ibaraki 1,051 2,989 Tochigi 711 2,088 Saitama 2,695 6,997 Chiba 2,379 6,015 Tokyo 5,862 12,168 Kanagawa 3,654 8,644 Yamanashi 322 881 Shutoken total 16,674 39,702 Shutoken’s share 33.1% 31.3%
Slide 47: Shutoken Sales by Product and Agency Recruitment
New Sales of WAYS (Six Months 2006) Shutoken: ¥1.4 billion 24.3% Whole Company (Excl. Shutoken) New Annualized Premium Sales by Product (Yen in Billions) Shutoken 0 2 4 6 8 10 12 14 6/05 6/06 5.8% Whole Company (Excl. Shutoken) 6/05 6/06 (4.9)% 0 10 20 30 40 50 60 Cancer Medical WAYS Other New Agenc
Slide 48: Training and Contribution from New Agencies
Tactics for Training New Agencies • Encourage them to participate in training • Accompany them when they visit a customer • Review training methods and materials to respond to the diversification of products Contribution from New Agencies (Yen in Billions) Shutoken* Whole Company** 8.8 ¥ 3.5 3.2 ¥9
Slide 49: Non-exclusive Agencies and Service Shops
Number of Non- Non-exclusive Agencies 500 454 441 400 367 283 300 200 100 0 2003 2004 2005 6/06 New Sales from Non- Non-exclusive Agencies (Yen in Billions) ¥ 2.5 2.2 2 1.8 1.5 1.5 1.1 1.0 1 0.5 0 2003 2004 2005 6/05 6/06 Contribution from Service Shops By Small and Medium Agencies* By Large Agencie
Slide 50: The Operations of an Affiliated Corporate Agency
Advantages and Challenges Advantages • Convenient access • Concentration of population Challenge • Increased competition The Operations of an Affiliated Corporate Agency Ichiro Yamada Senior Vice President, Wanbishi Archives Co., Ltd. 9
Slide 51: Overview of Wanbishi Archives
Overview of Wanbishi Archives z Year of foundation: 1966 (40th anniversary) z Sales in 2005: ¥16.5 billion z Number of employees: 556 (as of 4/1/2006) z Core businesses: ・ Records management business ・ Insurance business Problems with Paper Solicitation Method • Only periodic sales activity (once a
Slide 52: Face-to-Face Sales Representatives and New Sales
Number of Face-to-Face Sales Representatives Monthly Average 120 105 100 80 60 40 20 0 2001 2002 2003 2004 2005 2006 Comparison of New Sales (Yen in Millions) Regular employees Face-to-face sales reps. ¥ 900 800 700 600 500 400 300 200 100 0 2001 2002 2003 2004 2005 Number of Sales Offices 25 20 20
Slide 53: New Annualized Premium Sales and Premium Income
New Annualized Premium Sales (Yen in Millions) ¥1,400 1,200 1,000 800 600 400 200 0 2000 2001 2002 2003 2004 2005 2005 2006 Jan. – Jun. Premium Income (Yen in millions) ¥ 18,000 16,000 14,000 12,000 10,000 8,000 6,000 4,000 2,000 0 2000 2001 2002 2003 2004 2005 2005 2006 Jan. – Jun. Share of New Sal
Slide 54: The Operations of an Aflac Insurance Service Shop
Outlook • Promoting channel mix ・ Paper solicitation ・ Face-to-face sales ・ Sales outlets where customers visit ・ Direct mail ・ Call centers ・ Internet • Pursuing synergy effect with the records management business The Operations of an Aflac Insurance Service Shop Yukari Yamada President, My Communi
Slide 55: Number of Insurance Shops and My Communication Shops
Number of Insurance Shops 992 1,000 Non Aflac shops 900 Aflac Service Shops 800 627 700 600 500 400 300 300 158 200 100 0 2003 2004 2005 6/06 * Non Aflac shops include Hoken Ichiba, Life Plaza Holdings and other shops that are operated by GMS company affiliated agencies. My Communication Service Sho
Slide 56: Sales Composition and Customer Purchasing Process
Sales Composition by Product Cancer Medical Ordinary Other 100% 80% 60% 40% 20% 0% 2003 2004 2005 6/06 Annualized Premium in Force (Yen in Millions) ¥ 4,000 3,500 3,000 2,500 2,000 1,500 1,000 500 0 2003 2004 2005 6/06 Common Purchasing Process of Customers Purchasing Goods Attention Interest Desire
Slide 57: Purchasing Process, Alliance and Future Outlook
Purchasing Process at a Service Shop Attention Interest 1. Confirmation of the customer’s anxiety and risks Information 2. Importance of having coverage which fits his/her sentiment 3. Review of his/her existing policy 4. Necessary coverage for the future 5. How we can help him/her Access Considerat
Slide 58: Marketing Cancer Insurance through Dai-ichi Mutual Life
Marketing Cancer Insurance through Dai-ichi Mutual Life Takashi Nawa General Manager, Hachioji Branch, Dai-ichi Mutual Life Insurance Co. The Hachioji Branch Number of Divisions: 12 Number of Sales Reps.: 273 17
Slide 59: Advantages of Aflac's Cancer Insurance
Advantages of Aflac’s Cancer Insurance • Simple coverage • Obvious need in the market • Strong brand • Simple paperwork and quick claims payment Positioning of Cancer Insurance • Important means to support sales representatives’ income Income of Sales Representatives (Annual Average, Yen in Millions
Slide 60: Positioning of Cancer Insurance
Positioning of Cancer Insurance • Important means to support sales representatives’ income • Important means to increase base of potential customers Positioning of Cancer Insurance • Important means to support sales representatives’ income • Important means to increase base of potential customers •
Slide 61: Cancer Policy Sales and Selling Life Insurance to Cancer Policyholders
Cancer Policy Sales (Number of policies) 2,000 1,500 1,000 500 0 2004 2005 6/06 Retention Rate of Sales Representatives 70% 60 50 40 30 2004 2005 2006 Selling Life Insurance to Cancer Policyholders Cancer policyholders New customers: through Dai-ichi Life Do not have life insurance (About 260,000 pe
Slide 62: Potential for Selling Cancer Insurance to Dai-ichi's Policyholders
Potential for Selling Cancer Insurance to Dai-ichi’s Policyholders Already have cancer insurance : 6% Do not have cancer insurance : 94% 21